Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 384521 - 384540 out of 498428 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L01FF01) nivolumab | OPDIVO 10 mg/ml solution for injection | 1 Vial, 10ml, 10 mg/ml, Intravenous use, Solution for injection, 10mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | BRISTOL-MYERSSQUIBB / BRISTOL-MYERSSQUIBB |
| Saudi Arabia | (L01FF02) pembrolizumab | KEYTRUDA 25 mg/ml Concentrate For Solution For Infusion | 1 Vial, 4ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Endometrial Neoplasms | MERCKSHARP&DOHME / MSDINTERNATIONALGMBHT/AMSD |
| Saudi Arabia | (L01FF05) atezolizumab | TECENTRIQ 60 mg/ml Concentrate For Solution For Infusion | 1 Vial, 20ml, 60 mg/ml, Intravenous use, Injection, 60mg/ml , Vial, Injection | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | ROCHE / ROCHEDIAGNOSTICS |
| Saudi Arabia | (L01FG01) bevacizumab | AVASTIN 100 solution for infusion | 1 Vial, 4ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | ROCHE&COLTD / ROCHEDIAGNOSTICS |
| Saudi Arabia | (L01FG01) bevacizumab | AVASTIN 400 solution for infusion | 1 Vial, 16ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Ovarian Neoplasms; Colorectal Neoplasms; Carcinoma, Renal Cell | ROCHE&COLTD / ROCHEDIAGNOSTICS |
| Saudi Arabia | (L01FG01) bevacizumab | Zirabev | 1 Vial, 4ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | PfizerEuropeMAEEIG / PFIZER |
| Saudi Arabia | (L01FG01) bevacizumab | Zirabev | 1 Vial, 16ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms | PfizerEuropeMAEEIG / PFIZER |
| Saudi Arabia | (L01FX04) ipilimumab | YERVOY 5 mg/ml intravenous infusion | 1 Vial, 10ml, 5 mg/ml, Intravenous use, Intravenous infusion, 5mg/ml , Vial, Intravenous infusion | Retail price without vat |
$0-0 |
$0-0 |
Melanoma; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Mesothelioma, Malignant; Colorectal Neoplasms | BRISTOL-MYERSSQUIBB / BAXTERPHARMACEUTICALSOLUTIONLLC |
| Saudi Arabia | (L01FX17) sacituzumab govitecan | Trodelvy | 1 Vial, 180 mg, Intravenous use, Powder for concentrate for solution for infusion, 180mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms; Triple Negative Breast Neoplasms | GILEADSCIENCESLIMITED(CORK) / BSPPHARMACEUTICALS |
| Saudi Arabia | (L01FX18) amivantamab | Rybrevant 350 mg per 7 ml | 1 Vial, 7ml, 50 mg/ml, Intravenous use, Concentrate for solution for infusion, 50mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Janssen-CilagInternationalNV / CilagAG,Schaffhausen,Switzerland |
| Saudi Arabia | (L01FY01) pertuzumab and trastuzumab | Phesgo | 1 Vial, 15ml, 80,40 mg/ml, Subcutaneous use, Solution for injection, 80,40mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | F.Hoffmann-LaRocheLtd. / F.Hoffmann-LaRocheLtd. |
| Saudi Arabia | (L01FY01) pertuzumab and trastuzumab | Phesgo | 1 Vial, 10ml, 60,60 mg/ml, Subcutaneous use, Solution for injection, 60,60mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | F.Hoffmann-LaRocheLtd. / F.Hoffmann-LaRocheLtd. |
| Saudi Arabia | (L01XA01) cisplatin | CISPLATIN 0.5MG-ML INJ. | 1 Vial, 100ml, 0.5 mg/ml, Parenteral use, Concentrate for dispersion for injection, 0.5mg/ml , Vial, Concentrate for dispersion for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01XA01) cisplatin | CISPLATIN 0.5MG-ML INJ. | 1 Vial, 20ml, 0.5 mg/ml, Parenteral use, Concentrate for dispersion for injection, 0.5mg/ml , Vial, Concentrate for dispersion for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | EBEWEPHARMA / FarevaUnterachGmbH |
| Saudi Arabia | (L01XA01) cisplatin | CISPLATIN 1MG-1ML VIAL | 1 Vial, 50ml, 1 mg/ml, Parenteral use, concentrate for solution for injection, 1mg/ml , Vial, concentrate for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | HOSPIRAUKLIMITED / HOSPIRAAUSTRALIA |
| Saudi Arabia | (L01XA01) cisplatin | CIPALIN 0.5 mg/ml Vial | 1 Vial, 20ml, 10 mg, Intravenous use, Concentrate for solution for infusion, 10mg , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / THYMOORGANPHARMAZIEGMBH |
| Saudi Arabia | (L01XA01) cisplatin | CIPALIN 0.5 mg/ml Vial | 1 Vial, 50ml, 10 mg, Intravenous use, Concentrate for solution for infusion, 10mg , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / THYMOORGANPHARMAZIEGMBH |
| Saudi Arabia | (L01XA01) cisplatin | CIPALIN 0.5 mg/ml Vial | 1 Vial, 100ml, 10 mg, Intravenous use, Concentrate for solution for infusion, 10mg , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / THYMOORGANPHARMAZIEGMBH |
| Saudi Arabia | (L01XA01) cisplatin | Cisplatin 1 mg/ml VIAL | 1 Vial, 10ml, 1 mg/ml, Intravenous use, Solution for infusion, 1mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareLimited / INTASPHARMACEUTICALSLIMITED |
| Saudi Arabia | (L01XA01) cisplatin | Cisplatin 1 mg/ml VIAL | 1 Vial, 50ml, 1 mg/ml, Intravenous use, Solution for infusion, 1mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareLimited / INTASPHARMACEUTICALSLIMITED |
Pages
